Kintsugi is developing smarter mental healthcare infrastructure using voice biomarkers to streamline access to care. Awarded multiple distinctions for novel AI technology through the National Science Foundation, Kintsugi detects signs of clinical depression and anxiety from short clips of free-form speech, closing mental health care gaps across risk-bearing health systems, saving time and lives.As featured in Forbes (https://www.forbes.com/sites/ganeskesari/2021/05/24/ai-can-now-detect-depression-from-just-your-voice/), voice detects signs of a variety of health conditions, emotions, and diseases. Voice biomarkers allow us to predict the existence of disease, monitor progression or deterioration of disease or chronic condition, predict hospitalization and mortality, focus on patients in need, and as a result, optimize care and cost.We are truly excited to scale mental healthcare access for everyone in need.To learn more: https://www.kintsugihello.com